Liver problems after Capromorelin (Entyce) in cats
46 reports to the FDA describe liver problems in cats given Capromorelin. That is 5.6% of all reports for this medicine, compared with 2.8% across reports for all cat medicines, so it is reported unusually often with this medicine.
46Reports
89%Marked serious
15%Recovered
37%Died or euthanised
4 daysTypical onset
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Capromorelin stimulates appetite.
Products with this ingredient include Entyce, Elura. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Capromorelin cause liver problems in cats?
- 46 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 4 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Liver problems with similar medicines
- Liver problems after Maropitant (Cerenia) 331 reports · 8.6% of its reports
- Liver problems after Mirtazapine (Mirataz) 126 reports · 6.7% of its reports
All reported side effects of Capromorelin in cats · Medicines most reported with liver problems
